rs41274064
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2
The NM_032776.3(JMJD1C):c.5939C>T(p.Pro1980Leu) variant causes a missense change. The variant allele was found at a frequency of 0.0344 in 1,613,898 control chromosomes in the GnomAD database, including 1,144 homozygotes. In-silico tool predicts a benign outcome for this variant. 13/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.024 ( 65 hom., cov: 32)
Exomes 𝑓: 0.035 ( 1079 hom. )
Consequence
JMJD1C
NM_032776.3 missense
NM_032776.3 missense
Scores
1
17
Clinical Significance
Conservation
PhyloP100: 5.13
Genes affected
JMJD1C (HGNC:12313): (jumonji domain containing 1C) The protein encoded by this gene interacts with thyroid hormone receptors and contains a jumonji domain. It is a candidate histone demethylase and is thought to be a coactivator for key transcription factors. It plays a role in the DNA-damage response pathway by demethylating the mediator of DNA damage checkpoint 1 (MDC1) protein, and is required for the survival of acute myeloid leukemia. Mutations in this gene are associated with Rett syndrome and intellectual disability. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Dec 2015]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -20 ACMG points.
BP4
Computational evidence support a benign effect (MetaRNN=0.0031484067).
BP6
Variant 10-63193075-G-A is Benign according to our data. Variant chr10-63193075-G-A is described in ClinVar as [Benign]. Clinvar id is 460262.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr10-63193075-G-A is described in Lovd as [Benign].
BS1
Variant frequency is greater than expected in population nfe. gnomad4 allele frequency = 0.0241 (3662/152206) while in subpopulation NFE AF= 0.0392 (2663/68012). AF 95% confidence interval is 0.0379. There are 65 homozygotes in gnomad4. There are 1606 alleles in male gnomad4 subpopulation. Median coverage is 32. This position pass quality control queck.
BS2
High AC in GnomAd4 at 3662 AD gene.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
JMJD1C | NM_032776.3 | c.5939C>T | p.Pro1980Leu | missense_variant | 16/26 | ENST00000399262.7 | NP_116165.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
JMJD1C | ENST00000399262.7 | c.5939C>T | p.Pro1980Leu | missense_variant | 16/26 | 5 | NM_032776.3 | ENSP00000382204 |
Frequencies
GnomAD3 genomes AF: 0.0241 AC: 3662AN: 152088Hom.: 65 Cov.: 32
GnomAD3 genomes
AF:
AC:
3662
AN:
152088
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0253 AC: 6305AN: 249414Hom.: 110 AF XY: 0.0260 AC XY: 3524AN XY: 135314
GnomAD3 exomes
AF:
AC:
6305
AN:
249414
Hom.:
AF XY:
AC XY:
3524
AN XY:
135314
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0355 AC: 51858AN: 1461692Hom.: 1079 Cov.: 31 AF XY: 0.0350 AC XY: 25455AN XY: 727152
GnomAD4 exome
AF:
AC:
51858
AN:
1461692
Hom.:
Cov.:
31
AF XY:
AC XY:
25455
AN XY:
727152
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0241 AC: 3662AN: 152206Hom.: 65 Cov.: 32 AF XY: 0.0216 AC XY: 1606AN XY: 74410
GnomAD4 genome
AF:
AC:
3662
AN:
152206
Hom.:
Cov.:
32
AF XY:
AC XY:
1606
AN XY:
74410
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
TwinsUK
AF:
AC:
163
ALSPAC
AF:
AC:
167
ESP6500AA
AF:
AC:
23
ESP6500EA
AF:
AC:
289
ExAC
AF:
AC:
3040
Asia WGS
AF:
AC:
13
AN:
3478
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:1
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Early myoclonic encephalopathy Benign:1
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 30, 2024 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
DEOGEN2
Benign
.;T;.
Eigen
Benign
Eigen_PC
Benign
FATHMM_MKL
Uncertain
D
LIST_S2
Benign
T;T;T
MetaRNN
Benign
T;T;T
MetaSVM
Benign
T
MutationAssessor
Benign
.;N;.
MutationTaster
Benign
D;D;D;D
PrimateAI
Benign
T
PROVEAN
Benign
.;N;N
REVEL
Benign
Sift
Benign
.;T;D
Sift4G
Benign
.;T;T
Polyphen
0.0
.;B;.
Vest4
0.090, 0.15
MPC
0.14
ClinPred
T
GERP RS
RBP_binding_hub_radar
RBP_regulation_power_radar
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at